有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | (2R)-N-[(1R,2S)-2-methylcyclohexyl]-2-[(5-thiophen-2-yl-1H-1,2,4-triazol-3-yl)sulfanyl]propanamide | —— | C16H22N4OS2 |
|
—— | N-[(1R)-1-(4-ethylphenyl)ethyl]-2-[(5-thiophen-2-yl-1H-1,2,4-triazol-3-yl)sulfanyl]acetamide | —— | C18H20N4OS2 |
|
—— | 6-Amino-1-cyclopropyl-5-[2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]acetyl]pyrimidine-2,4-dione | —— | C13H14N4O3S2 |
|
—— | 6-Amino-5-[2-[(5-benzyl-1,3,4-oxadiazol-2-yl)sulfanyl]acetyl]-1-cyclopropylpyrimidine-2,4-dione | —— | C18H17N5O4S |
|
—— | 2-(4-chlorophenyl)-5-[(5-thiophen-2-yl-1H-1,2,4-triazol-3-yl)sulfanylmethyl]-1,3,4-oxadiazole | —— | C15H10ClN5OS2 |
|
—— | N-[2-(4-methoxyphenoxy)ethyl]-N-methyl-2-phenylsulfanylpyridine-3-carboxamide | —— | C22H22N2O3S |
|
—— | 3-[(3-fluorophenyl)methylsulfanyl]-5-thiophen-2-yl-1H-1,2,4-triazole | —— | C13H10FN3S2 |
|
—— | N-[(1S)-1-(4-ethylphenyl)ethyl]-2-[(5-thiophen-2-yl-1H-1,2,4-triazol-3-yl)sulfanyl]acetamide | —— | C18H20N4OS2 |
|
—— | 2-[(1-Cyclopentyltetrazol-5-yl)sulfanylmethyl]-5-(3-methylphenyl)-1,3,4-oxadiazole | —— | C16H18N6OS |
|
—— | N-[2-(cyclohexen-1-yl)ethyl]-2-[(5-thiophen-2-yl-1H-1,2,4-triazol-3-yl)sulfanyl]acetamide | —— | C16H20N4OS2 |
|
—— | 1-(1-ethyl-2,5-dimethylpyrrol-3-yl)-2-[(5-thiophen-2-yl-1H-1,2,4-triazol-3-yl)sulfanyl]ethanone | —— | C16H18N4OS2 |
|
—— | 5-(3,4-Dimethoxyphenyl)-2-methyl-4-pyrimidin-2-ylsulfanylthieno[2,3-d]pyrimidine | —— | C19H16N4O2S2 |
|
—— | 5-(4-Chlorophenyl)-4-(1-cyclopropyltetrazol-5-yl)sulfanylthieno[2,3-d]pyrimidine | —— | C16H11ClN6S2 |
|
—— | 6-Amino-1-cyclopropyl-5-[2-(1-methylimidazol-2-yl)sulfanylacetyl]pyrimidine-2,4-dione | —— | C13H15N5O3S |
|
—— | 6-Amino-1-cyclopropyl-5-(2-pyrimidin-2-ylsulfanylacetyl)pyrimidine-2,4-dione | —— | C13H13N5O3S |
|
—— | 6-(2,3-Dihydro-1,4-benzodioxin-6-ylsulfanyl)pyridine-3-sulfonamide | —— | C13H12N2O4S2 |
|
—— | (4-methylsulfanylphenyl)methyl N'-propan-2-ylcarbamimidothioate | —— | C12H18N2S2 |
|
—— | N-[2-(4-methylphenyl)sulfanylethyl]-2-(1-oxidopyridin-1-ium-2-yl)oxyacetamide | —— | C16H18N2O3S |
|
—— | N-[2-(4-chlorophenyl)sulfanylphenyl]-2-([1,2,4]triazolo[4,3-a]pyridin-3-yloxy)acetamide | —— | C20H15ClN4O2S |
|
—— | 1-[2-(4-Chlorophenyl)sulfanylethyl]-3,5-dimethyl-4-nitropyrazole | —— | C13H14ClN3O2S |
|
—— | N-[2-(4-chlorophenyl)sulfanylphenyl]-2-(1-oxidopyridin-1-ium-2-yl)oxyacetamide | —— | C19H15ClN2O3S |
|
—— | (3S)-1-tert-butyl-5-oxo-N-(2-phenylsulfanylphenyl)pyrrolidine-3-carboxamide | —— | C21H24N2O2S |
|
—— | (3R)-1-tert-butyl-5-oxo-N-(2-phenylsulfanylphenyl)pyrrolidine-3-carboxamide | —— | C21H24N2O2S |
|
—— | 4-cyclopropyl-3-(2-methylprop-2-enylsulfanyl)-1H-1,2,4-triazol-5-one | —— | C9H13N3OS |
|
—— | N-[(1R)-1-(furan-2-yl)ethyl]-2-pyridin-2-ylsulfanylacetamide | —— | C13H14N2O2S |
|
—— | 2-(5-Bromothiophen-2-yl)-5-(pyridin-2-ylsulfanylmethyl)-1,3,4-oxadiazole | —— | C12H8BrN3OS2 |
|
—— | N-benzyl-N-[(3S)-1,1-dioxo-2,3-dihydrothiophen-3-yl]-2-pyridin-2-ylsulfanylacetamide | —— | C18H18N2O3S2 |
|
—— | N-[(2-fluorophenyl)methyl]-2-pyridin-2-ylsulfanylacetamide | —— | C14H13FN2OS |
|
—— | 4-cyclopropyl-3-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]methylsulfanyl]-1H-1,2,4-triazol-5-one | —— | C12H11N5O3S |
|
—— | 1-(4-Benzylsulfonylpiperazin-1-yl)-2-pyridin-2-ylsulfanylethanone | —— | C18H21N3O3S2 |
|
—— | 4-cyclopropyl-3-[[2-(4-methylanilino)-1,3-thiazol-4-yl]methylsulfanyl]-1H-1,2,4-triazol-5-one | —— | C16H17N5OS2 |
|
—— | 4-cyclopropyl-3-[(4-methylphenyl)methylsulfanyl]-1H-1,2,4-triazol-5-one | —— | C13H15N3OS |
|
—— | N-(6-amino-1-butyl-2,4-dioxopyrimidin-5-yl)-N-cyclopentyl-2-pyridin-2-ylsulfanylacetamide | —— | C20H27N5O3S |
|
—— | 4-cyclopropyl-3-[(2-phenyl-1,3-thiazol-4-yl)methylsulfanyl]-1H-1,2,4-triazol-5-one | —— | C15H14N4OS2 |
|
—— | 4-cyclopropyl-3-[2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-2-oxoethyl]sulfanyl-1H-1,2,4-triazol-5-one | —— | C13H20N4O3S |
|
—— | 4-cyclopropyl-3-[2-[(2S,6S)-2,6-dimethylmorpholin-4-yl]-2-oxoethyl]sulfanyl-1H-1,2,4-triazol-5-one | —— | C13H20N4O3S |
|
—— | 4-Cyclopropyl-5-((2-oxo-2-(thiophen-2-yl)ethyl)thio)-2,4-dihydro-3h-1,2,4-triazol-3-one | —— | C11H11N3O2S2 |
|
—— | N-(6-amino-1-butyl-2,4-dioxopyrimidin-5-yl)-N-ethyl-2-pyridin-2-ylsulfanylacetamide | —— | C17H23N5O3S |
|
—— | N-[[5-(4-chlorophenyl)furan-2-yl]methyl]-N-methyl-2-pyridin-2-ylsulfanylacetamide | —— | C19H17ClN2O2S |
|
—— | N-[(1S)-1-(furan-2-yl)ethyl]-2-[[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C17H17N3O3S |
|
—— | 4-cyclopropyl-3-(2-hydroxyethylsulfanyl)-1H-1,2,4-triazol-5-one | —— | C7H11N3O2S |
|
—— | N-[(2R)-heptan-2-yl]-2-[[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C18H25N3O2S |
|
—— | N-[(1R)-1-(furan-2-yl)ethyl]-2-[[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C17H17N3O3S |
|
—— | N-[(2R)-5-methylhexan-2-yl]-2-[[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C18H25N3O2S |
|
—— | N-[(2S)-6-methylheptan-2-yl]-2-[[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C19H27N3O2S |
|
—— | N-[(1R)-1-cyclopropylethyl]-2-[[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C16H19N3O2S |
|
—— | 4-cyclopropyl-3-(2-ethoxyethylsulfanyl)-1H-1,2,4-triazol-5-one | —— | C9H15N3O2S |
|
—— | 2-[[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[(2R)-octan-2-yl]acetamide | —— | C19H27N3O2S |
|
—— | 2-[[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-pentylacetamide | —— | C16H21N3O2S |
|
—— | N-methyl-2-[[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[(3-methylthiophen-2-yl)methyl]acetamide | —— | C18H19N3O2S2 |
|